CADTH.ca

Begin main content

COVID-19 and Pharmaceutical Reviews: Read Our FAQs

Featured Reports

New at CADTH - November 2020

News and Events CADTH’s 2020 Virtual Symposium: A Success! CADTH successfully wrapped up our first-ever virtual Symposium that was he...

Last updated: September 9, 2020

Care for Acquired Brain Injury and Concurrent Mental Health Conditions and/or Substance Use Disorders

Summary The overall objectives of this Environmental Scan were to identify Canadian integrated care systems and programs for the care ...

Last updated: July 10, 2020

New at CADTH - October 2020

News and Events Aligned Drug Reimbursement Review Process Announced CADTH has taken a significant step forward in making its Pharmace...

Last updated: September 9, 2020

View all Reports

Upcoming Events

CADTH COVID-19 Webinar - Community-Based Aerosol Transmission Of COVID-19 and HVAC Systems

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, spreads when an infected person breathes out, sn...

Event Date: December 3, 2020

View all Events

News Feed

CADTH Recommends First Gene Therapy Treatment for Rare Form of Childhood Vision Loss

Voretigene neparvovec (Luxturna) is the first gene therapy evaluated through the CADTH reimbursement review process CADTH recommend...

Published on: November 26, 2020

2020 Virtual CADTH Symposium - New Content Available

Did you miss some of the great live sessions during the 2020 Virtual CADTH Symposium? Great news — our plenary and concurrent sessions a...

Published on: November 25, 2020

Statement from Suzanne McGurn, CADTH President and CEO, on Digital Health Week

After a Breakout Year for Digital Health, What’s Next? This week, I’m proud to join Canadian health system leaders in celebrating Digita...

Published on: November 16, 2020

View all News